Abstract:Context.-Primary pulmonary neuroendocrine tumors are traditionally classified into 3 major types: typical carcinoid (TC), atypical carcinoid (AC), and large cell neuroendocrine carcinoma (LC) or small cell neuroendocrine carcinoma (SC). Confusion arises frequently regarding the malignant nature of TC and the morphologic differentiation between AC and LC or SC.Objective.-To provide clinicopathologic evidence to streamline and clarify the histomorphologic criteria for this group of tumors, emphasizing the prognostic implications.Patients.-To minimize variability in diagnostic criteria and treatment plans, we analyzed a group of patients whose diagnosis and treatment occurred at a single institution. We reviewed 234 cases of primary pulmonary neuroendocrine tumors and thoroughly studied 50 cases of resected tumors from 1986 to 1995.Results-On the basis of morphologic characteristics and biologic behaviors of the tumors, we agree with many previous investigators that these tumors are all malignant and potentially aggressive. Based on our accumulated data, we have modified Gould criteria and reclassified these tumors into 5 types: (1) well-differentiated neuroendocrine carcinoma (otherwise called TC) (14 cases, with less than 1 mitosis per 10 high-power fields [HPF] with or without minimal necrosis); (2) moderately differentiated neuroendocrine carcinoma (otherwise called low-grade AC) (6 cases, with less than 10 mitoses per 10 HPF and necrosis evident at high magnification); (3) poorly differentiated neuroendocrine carcinoma (otherwise called high-grade AC) (110 cases, with more than 10 mitoses per 10 HPF and necrosis evident at low-power magnification); (4) undifferentiated LC (5 cases, with more than 30 mitoses per 10 HPF and marked necrosis); and (5) undifferentiated SC (15 cases, with more than 30 mitoses per 10 HPF and marked necrosis). The 5-year survival rates were 93%, 83%, 70%, 60%, and 40% for well, moderately, and poorly differentiated, and undifferentiated large cell and small cell neuroendocrine carcinomas, respectively. We found nodal metastasis in 28% of TC in this retrospective review, a figure higher than previously recorded.Conclusion.-Using a grading system and terms comparable to those used for many years and used for neuroendocrine tumors elsewhere in the body, we found that classification of pulmonary neuroendocrine carcinomas as well, moderately, poorly differentiated, or undifferentiated provides prognostic information and avoids misleading terms and concepts. This facilitates communication between pathologists and clinicians and thereby improves diagnosis and management of the patient.

Analysis on the Characteristics and Prognosis of Pulmonary Neuroendocrine Tumors.

Clinical Prognostic Factors for Central Neurocytoma and Subgroup Analysis of Different Treatment Measures: A SEER Database-Based Retrospective Analysis from 2003 to 2019

Characteristics and Prognosis of 127 Cases with Bronchopulmonary Neuroendocrine Tumors

Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendo-crine tumor

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis

Assessment of the Prognostic Factors in Patients with Pulmonary Carcinoid Tumor: a Population‐based Study

[The Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms].

Surgical Treatment for Pulmonary Carcinoid Tumors: a Single-Center Analysis of 62 Patients

Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis

The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors

Clinicopathological Features And Prognostic Factors Of Colorectal Neuroendocrine Neoplasms

Clinical Features And Outcomes Analysis Of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant Chemotherapy

Diagnosis, Treatment and Prognosis of 27 Patients with Primary Lung Carcinoids

[Prognostic Factor Analysis of Surgical Treatment in Patients with Rectal Neuroendocrine Neoplasms].

[Investigation of Long-Term Outcome for Lung Cancer of Patients with Neoadjuvant Chemotherapy].

Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience

[Clinicopathological Characteristics and Prognosis Analysis of 39 Patients with Pulmonary Sarcomatoid Carcinoma]

Pancreatic neuroendocrine carcinoma: clinicopathological characteristics and prognosis

Pulmonary Neuroendocrine Carcinomas - A Review Of 234 Cases And A Statistical Analysis Of 50 Cases Treated At One Institution Using A Simple Clinicopathologic Classification

Clinical characteristics and prognostic factors of patients with gastric neuroendocrine carcinoma treated with radical surgery.